Indefinite Delivery Contract 75D30125D20483
Award Date
7/1/25
Last Date to Order
6/30/26
Federal Agency
CDC Pittsburgh
Awardee
Sanofi Pasteur Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccines and medical supplies. The $15,226,000 multiple-award contract covers the procurement of adult COVID-19 vaccines for the period of June 1, 2025 through May 31, 2026. As a leading global vaccine provider, Sanofi Pasteur has secured numerous significant IDCs across various federal...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer of vaccines and medical supplies. The contract, valued at $163,144,080.00, is for the procurement of pediatric flu vaccines for the 2025-2026 fiscal year. The IDC is a multiple-award vehicle that will allow the CDC to issue task orders for the delivery of the required vaccines over the contract's period of...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The contract, valued at a ceiling of $669,123,533.05, is for the provision of various vaccine products and related services to support public health missions across multiple federal agencies. The scope of the IDC includes seasonal and pre-pandemic influenza vaccines,...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The $640,309,577 multiple-award contract, identified as VFA 2009, has an ultimate completion date of June 30, 2010. Under this IDC, Sanofi Pasteur Inc. is the prime contractor responsible for providing a range of vaccine products and services to support various federal...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals and medical goods. The $26.5 million single-award IDC, awarded on March 15, 2010 with a final completion date of February 28, 2011, provides for the delivery of a variety of vaccine products and related services to support the CDC's public health preparedness and...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc. as the prime contractor. The contract has a ceiling value of $1,219,916,713.60 and a period of performance through January 31, 2011. Under this IDC, Sanofi Pasteur Inc. is providing a range of vaccine products and services to support disease prevention and maintain public health preparedness for federal agencies including the Department...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Sanofi Pasteur Inc. The 5-year contract, valued at a ceiling of $1,996,408,200.00, is for the provision of standard commercial pediatric vaccines to support the Vaccines for Children (VFC) program. As the prime contractor, Sanofi Pasteur Inc. will be required to deliver a variety of vaccine types to CDC distribution centers within 15 working days, including...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. to provide adult flu vaccines for the 2024-2025 season. The contract has a ceiling value of $64,529,958.50 and a period of performance through February 28, 2025. As the prime contractor, Sanofi Pasteur Inc. will leverage its pharmaceutical manufacturing and distribution capabilities to efficiently fulfill CDC's requirements for seasonal influenza vaccines to...
This indefinite delivery contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services, to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccines. The contract, valued at a ceiling of $6,294,039,491.48, is for the development and domestic manufacture of adjuvanted, pandemic influenza vaccines. As a leading global vaccine provider, Sanofi...
The federal contract IDV award was granted to Sanofi Pasteur Inc., a vaccine and pharmaceutical manufacturer, by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency. The single-award Indefinite Delivery Contract, valued at up to $9,702,459.30, covers the delivery of various vaccine products and services to support public health preparedness and disease prevention missions of multiple government agencies. This includes seasonal and...